NeoModulus (Suzhou) Medical Technology Continues Its Five-Year Streak on Jiangsu's 2024 List of Potential Unicorn Enterprises

On September 24, 2024, the Jiangsu Productivity Promotion Center organized the "Release Conference of the 2024 Jiangsu Unicorn and Gazelle Enterprises Evaluation Results," announcing the evaluation results for enterprises selected as Jiangsu unicorns, potential unicorns, and gazelles.Neo Modulus has been selected for the list of Jiangsu Province's potential unicorn enterprises for five consecutive years due to its technological innovation capabilities in the high-end medical device field., marking Neo Modulus as one of the important participants and promoters of new productive forces in the industry, has made positive contributions in driving regional scientific and technological innovation, exploring new fields and tracks, and shaping new drivers and advantages for development.

▲ 2024 Jiangsu Province Potential Unicorn Enterprise Partial List

Potential Unicorn EnterpriseIt refers to high-growth innovative enterprises that are newly established for no more than 5 years with a valuation of no less than 0.5 billion US dollars, or newly established for 5 to 9 years with a valuation between 1 to 10 billion US dollars, have received private equity investment, and are not yet listed. The key evaluation criteria for unicorn companies include: whether the company has a high post-financing valuation and is highly recognized by the capital market; whether the company possesses key core technologies and its main products have prominent market advantages; and whether the company's business operations are in good condition.

Neo ModulusAs an innovative pioneer in the field of regenerative implantable medical devices, Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. actively responds to national calls and consistently adheres to the development philosophy of innovation and internationalization. The company's independently developed Class III medical device, "WenNuo,"®Gelatin-Polycaprolactone Layered Gingival Repair Membrane" "Neo Modulus®Dental Bone Grafting Materialand IIClassMedical Device "Oleyu"®"Expanding Hemostatic Sponge" "Pinyu"®"Medical Adhesive" and other productsHave all been approved for marketing,Among them, "Neo®"Gingival Repair Membrane" is the first domestically approved Class III passive implantable national innovative dental instrument in China, "Oleyu®"Expansive Hemostatic Sponge" has been obtainedMDR CE Certification, gradually making a name for itself in the global market. Currently, Neo Modulus is steadily advancing the research and development as well as clinical trials of a series of innovative products, covering multiple fields such as dentistry, ophthalmology, reproductive medicine, and sports medicine, showcasing strong R&D capabilities and development potential.Being rated as a potential unicorn enterprise for five consecutive years is not only an authoritative recognition of Neo Modulus's innovative capabilities but also a strong support for its vision of international development.。

In the future, Neo Modulus will continue to tackle cutting-edge technologies in tissue engineering, solve challenging problems in the global regenerative medicine field, fulfill social responsibilities through technological strength, and promote the vigorous development of China's new quality productive forces.

Statement:

This article is for news purposes only, and its content is solely intended for information dissemination or industry exchange.Nothing herein shall be construed as advertising or constituting any express or implied advertisement, nor shall it be deemed to have any purpose of sale or promise of sale.For accurate information, please consult a professional medical institution for expert advice.

If any individual or media outlet, website wishes to reprint this article, please contact the official account for authorization and indicate the source of the reprint.